Other Indications Under Study Type 2 Diabetes (TRANSCEND-T2D) TRANSCEND-T2D-1 was the first Phase 3 readout in type 2 diabetes, with Lilly reporting results on March 19, 2026
A study in the New England Journal of Medicine highlighted that participants using a GLP-1 experienced weight loss that included both fat and lean mass
Eligibility requires BMI 30, or BMI 27 with conditions like high blood pressure, sleep apnea, or prediabetesyou'll need recent weight and blood pressure measurements for assessment
La souscription de tout sjour implique une acceptation sans rserve, par le Participant ainsi que par tout autre participant, des prsentes Conditions Gnrales de Vente, dont il reconnait avoir pris connaissance avant la validation de sa rservation
Ozempic is a prescription medication that should only be used under the supervision of a licensed healthcare provider
The Weight Hacker: Women who want to lose weight in a healthier way, without going on dangerous medications